Company Filing History:
Years Active: 2024-2025
Title: Patricia Lepage: Innovator in Pulmonary Health
Introduction
Patricia Lepage is a notable inventor based in Jouy-en-Josas, France. She has made significant contributions to the field of pulmonary health, particularly in understanding the microbiota's role in respiratory infections. With a total of 2 patents, her work has the potential to impact the treatment and management of cystic fibrosis.
Latest Patents
Lepage's latest patents focus on methods for predicting the risk of developing pulmonary colonization and infection. The inventions involve analyzing the respiratory tract microbiota from sputum samples of patients. The research revealed that patients who remained uninfected exhibited a three-fold higher abundance of specific bacteria compared to those who developed infections. One of the key methods involves measuring the abundance of certain genera of bacteria in biological samples from subjects suffering from cystic fibrosis.
Career Highlights
Throughout her career, Patricia Lepage has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre Hospitalier Régional et Universitaire de Brest. Her research has contributed to a deeper understanding of pulmonary health and the factors influencing respiratory infections.
Collaborations
Lepage has collaborated with notable colleagues, including Geneviève Hery-Arnaud and Jérôme Mounier. These partnerships have enhanced her research and expanded the impact of her findings in the medical community.
Conclusion
Patricia Lepage's innovative work in predicting pulmonary infections showcases her dedication to improving health outcomes for patients with cystic fibrosis. Her contributions to the field are invaluable and highlight the importance of research in understanding complex health issues.